My second brain on Android ...

Syncing notes across devices isn’t just a convenience; it’s a necessity for many. Imagine taking notes on your laptop during a meeting and needing to reference them later on your tablet or smartphone.

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Long-Term Issue Credit Rating (Long-Term IR) of “a” (Excellent) on the $1.654 billion (which upsized to $1.805 billion outstanding as of March ...

Teenage risk-taking, such as experimentation with alcohol, cannabis, nicotine and other substances, may reflect a compensatory response to lower baseline dopamine, the brain chemical for reward ...

A major study suggests glucosamine, a popular supplement for joint pain, could be linked to faster progression from mild cognitive impairment to Alzheimer’s disease. Researchers found a 25% higher ...

Rejoice, LinkedIn game players. There's a new game available, and it's going to test your word puzzle and logic skills. The career-based website released its eighth game on Tuesday morning, ...

The reMarkable Paper Pure offers the best digital canvas for note-taking that I've experienced lately. But this excellent slate is held back by a restrictive software experience.

A couple of years ago I found myself frustrated by trying to take notes at a press briefing using my laptop, phone, or any other piece of electronic technology I had on hand. As such, I grabbed a ...

In a recent SEC filing, AI Financial has indicated that it may not be able to survive another year writing, “These conditions raise substantial doubt about the Company’s ability to continue as a going ...

XRP slipped back below $1.40 after a failed push toward $1.42, as traders took profits aggressively into the rally. The token remains locked in a months-long symmetrical triangle, with tightening ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Several Democratic candidates running in competitive Senate primaries ...

Breast cancer patients with obesity or Type 2 diabetes who used GLP-1s had lower all-cause mortality and risk of recurrence, according to a study published May 11 in JAMA Network Open. Researchers ...